Pacira BioSciences, Inc. PCRX Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Pacira BioSciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s gross margin?
- Pacira BioSciences, Inc. (PCRX) reported gross margin of 79.3% in Q1 2026.
- How has Pacira BioSciences, Inc.'s gross margin changed year-over-year?
- Pacira BioSciences, Inc.'s gross margin increased by 2.2% year-over-year, from 77.6% to 79.3%.
- What is the long-term trend for Pacira BioSciences, Inc.'s gross margin?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s gross margin has grown at a 1.8% compound annual growth rate (CAGR), from 72.7% to 79.4%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.